Skip to main content

aztreonam/avibactam

J - Antiinfectives For Systemic Use -> J01 - Antibacterials For Systemic Use -> J01D - Other Beta-Lactam Antibacterials -> J01DF - Monobactams -> J01DF01 - Aztreonam
Administration category: Limited Medicine group: antibacterial Brand name: Emblaveo

Standard dosages

≥ 18 years
Weight ROA Load Dosage
ROA:
iv
Load:
2g/0.67g
Dosage:
1.5/0.5g 4 dd
Comments:

Intraveneuze toediening als infusie in 3 uur

Dosage for "I" sensitivity

≥ 18 years
Weight ROA Load Dosage
ROA:
iv
Load:
-
Dosage:
Comments:

tbd

Kidney function

ROA GFR Dosage Interval Comments
ROA:
GFR:
30 - 60
Dosage:
normale aanvangsdosis, vervolgens 3/1 g per 24 uur continu of 0.75/0.25 elke 6 uur
GFR:
15 - 30
Dosage:
normale aanvangsdosis, vervolgens 2.25/0.75 g per 24 uur continu of 0.75/0.25 elke 8 uur
GFR:
<15
Dosage:
normale aanvangsdosis, vervolgens 1.5/0.5 g per 24 uur continu of 0.75/0.25 elke 12 uur
Renal elimination: 75-80%
Dosage: dependent on kidney function

Renal function-replacement therapy

CAPD: geen gegevens bekend

HDF: hemo(dia)filtratie: normale aanvangsdosis, vervolgens 3/1 g per 24 uur continu of 0.75/0.25 elke 6 uur

Hemo dialysis: intermitterende hemodialyse: normale aanvangsdosis, vervolgens 1.5/0.5 g per 24 uur continu of 0.75/0.25 elke 12 uur; continue venoveneuze hemodialyse: normale aanvangsdosis, vervolgens 3/1 g per 24 uur continu of 0.75/0.25 elke 6 uur

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.
Metadata

Swab vid: M-502446.4
Updated: 04/28/2026 - 17:49
Status: Published

Menu position